Paget's disease: Epidemiology and pathophysiology

Current Osteoporosis Reports

Volumn 6, Issue 4, 2008, Pages 125-129

  Seton, Margaret ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P62; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

AGING; BONE DISEASE; BONE REMODELING; CELL ACTIVATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; MYOPATHY; NONHUMAN; ONSET AGE; OSTEOCLAST; PAGET BONE DISEASE; PARAMYXOVIRUS; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SIGNAL TRANSDUCTION; ARTICLE; GENETICS; MUTATION; VIROLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; HUMANS; MUTATION; OSTEITIS DEFORMANS; OSTEOCLASTS; PARAMYXOVIRINAE;

EID: 61449396014     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-008-0022-8     Document Type: Review

References (57)

1. Paget SJ: On a form of chronic inflammation of bones (osteitis deformans). Med Chir Trans 1877, 60:37-64.9.
2. NagantdedeuxchaisneC C, Krane SM: Paget's disease of bone: clinical and metabolic observations. Medicine 1964, 43:233-266.
3. Schmorl G: Ueber ostitis deformans Paget. Virchows Arch Pathol Anat 1932, 283:694-751.
4. Terry TL: Angioid streaks and osteitis deformans. Trans Am Ophthalmol Soc 1934, 32:555-573.
5. Collins DH: Paget's disease of bone; incidence and subclinical forms. Lancet 1956, 271:51-57.
6. Barker DJ, Gardner MJ: Distribution of Paget's disease in England, Wales and Scotland and a possible relationship with vitamin D deficiency in childhood. Br J Prev Soc Med 1974, 28:226-232.
7. Rosenbaum HD, Hanson DJ: Geographic variation in the prevalence of Paget's disease of bone. Radiology 1969, 92:959-963.
8. Altman RD, Bloch DA, Hochberg MC, Murphy WA: Prevalence of pelvic Paget's disease of bone in the United States. J Bone Miner Res 2000, 15:461-465.
9. Tiegs RD, Lohse CM, Wollan PC, Melton LJ: Long-term trends in the incidence of Paget's disease of bone. Bone 2000, 27:423-427.
10. Cooper C, Schafheutle K, Dennison E, et al.: The epidemiology of Paget's disease in Britain: Is the prevalence decreasing? J Bone Miner Res 1999, 14:192-197.
11. Doyle T, Gunn J, Anderson G, et al.: Paget's disease in New Zealand: evidence for declining prevalence. Bone 2002, 31:616-619.
12. Morales-Piga AA, Bachiller-Corral FJ, Abraira V, et al.: Is clinical expressiveness of Paget's disease of bone decreasing? Bone 2002, 30:399-403.
13. Cundy HR, Gamble G, Wattie D, et al.: Paget's disease of bone in New Zealand: Continued decline in disease severity. Calcif Tissue Int 2004, 75:358-364.
14. Poor G, Donath J, Fornet B, Cooper C: Epidemiology of Paget's disease in Europe: The prevalence is decreasing. J Bone Miner Res 2006, 21:1545-1549.
15. Haddaway MJ, Davie MW, McCall IW, Howdle S: Effect of age and gender on the number and distribution of sites in Paget's disease of bone. Br J Radiol 2007, 80:532-536.
16. Gennari L, Di Stefano M, Merlotti D, et al.: Prevalence of Paget's disease of bone in Italy. J Bone Miner Res 2005, 20:1845-1850.
17. Rendina D, Gennari L, De Filippo G, et al.: Evidence for increased clinical severity of familial and sporadic Paget's disease of bone in Campania, southern Italy. J Bone Miner Res 2006, 21:1828-1835.
18. Siris ES, Ottman R, Flaster E, Kelsey JL: Familial aggregation of Paget's disease of bone. J Bone Miner Res 1991, 6:495-500.
19. Seton M, Choi HK, Hansen MF, et al.: Analysis of environmental factors in familial versus sporadic Paget's disease of bone - the New England Registry for Paget's Disease of Bone. J Bone Miner Res 2003, 18:1519-1524.
20. Laurin N, Brown JP, Morissette J, Raymond V: Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 2002, 70:1582-1588.
21. MorissetteMJ, Laurin N, Brown JP: Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone. J Bone Miner Res 2006, 21(Suppl 2):P38-P44.
22. Bolland MJ, Tong PC, Naot D, et al.: Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res 2007, 22:411-415.
23. Good DA, Busfield F, Fletcher BH, et al.: Identification of SQSTM1 mutations in familial Paget's disease in Australian pedigrees. Bone 2004, 35:277-282.
24. Beyens G, Van Hul E, Van Driessche K, et al.: Evaluation of the role of the SQSTM1 gene in sporadic Belgian patients with Paget's disease. Calcif Tissue Int 2004, 75:144-152.
25. Rhodes EC, Johnson-Pais TL, Singer FR, et al.: Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States. Calcif Tissue Int 2008, 82:271-277.
26. Lucas GJ, Hocking LJ, Daroszewska A, et al.: Ubiquitinassociated domain mutations of SQSTM1 in Paget's disease of bone: Evidence for a founder effect in patients of British descent. J Bone Miner Res 2005, 20:227-231.
27. Chung PY, Beyens G, Guanabens N, et al.: Founder effect in different European countries for the recurrent P392L SQSTM1 mutation in Paget's disease of bone. Calcif Tissue Int 2008, 83:34-42.
28. Long J, Gallagher TR, Cavey JR, et al.: Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. J Biol Chem 2008, 283:5427-5440.
29. Hocking LJ, Lucas GJ, Daroszewska A, et al.: Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: Genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res 2004, 19:1122-1127.
30. Eekhoff EW, Karperien M, Houtsma D, et al.: Familial Paget's disease in The Netherlands: Occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 2004, 50:1650-1654.
31. Rea SL, Walsh JP, Ward L, et al.: A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF-kappaB signaling and Paget's disease of bone with a severe phenotype. J Bone Miner Res 2006, 21:1136-1145.
32. Collet C, Michou L, Audran M, et al.: Paget's disease of bone in the French population: Novel SQSTM1 mutations, functional analysis, and genotype-phenotype correlations. J Bone Miner Res 2007, 22:310-317.
33. Geetha T, Wooten MW: Structure and functional properties of the ubiquitin binding protein p62. FEBS Lett 2002, 512:19-24.
34. Layfield R, Shaw B: Ubiquitin-mediated signalling and Paget's disease of bone. BMC Biochem 2007, 8(Suppl 1):S5.
35. Duran A, Serrano M, Leitges M, et al.: The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell 2004, 6:303-309.
36. Kurihara N, Hiruma Y, Zhou H, et al.: Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest 2007, 117:133-142.
37. Rebel A, Basle M, Pouplard A, et al.: Towards a viral etiology for Paget's disease of bone. Metab Bone Dis Relat Res 1981, 3:235-238.
38. Mills BG, Singer FR, Weiner LP, Holst PA: Cell cultures from bone affected by Paget's disease. Arthritis Rheum 1980, 23:1115-1120.
39. Mee AP, Dixon JA, Hoyland JA, et al.: Detection of canine distemper virus in 100% of Paget's disease samples by in situ-reverse transcriptase-polymerase chain reaction. Bone 1998, 23:171-175.
40. Reddy SV, Menaa C, Singer FR, et al.: Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone. Exp Hematol 1999, 27:1528-1532.
41. Reddy SV, Singer FR, Roodman GD: Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 1995, 80:2108-2111.
42. Khan SA, Brennan P, Newman J, et al.: Paget's disease of bone and unvaccinated dogs. Bone 1996, 19:47-50.
43. Kurihara N, Zhou H, Reddy SV, et al.: Experimental models of Paget's disease. J Bone Miner Res 2006, 21(Suppl 2):P55-P57.
44. Selby PL, Davies M, Mee AP: Canine distemper virus induces human osteoclastogenesis through NF-kappaB and sequestosome 1/P62 activation. J Bone Miner Res 2006, 21:1750-1756.
45. Ooi CG, Walsh CA, Gallagher JA, Fraser WD: Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 2000, 27:417-421.
46. Helfrich MH, Hobson RP, Grabowski PS, et al.: A negative search for a paramyxoviral etiology of Paget's disease of bone: Molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res 2000, 15:2315-2329.
47. Matthews BG, Afzal MA, Minor PD, et al.: Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease. J Clin Endocrinol Metab 2008, 93:1398-1401.
48. Helfrich MH, Hocking LJ: Genetics and aetiology of Pagetic disorders of bone. Arch Biochem Biophys 2008, 473:172-182.
49. Naot D, Bava U, Matthews B, et al.: Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res 2007, 22:298-309.
50. Hughes AE, Ralston SH, Marken J, et al.: Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 2000, 24:45-48.
51. Osterberg PH, Wallace RG, Adams DA, et al.: Familial expansile osteolysis. A new dysplasia. J Bone Joint Surg Br 1988, 70:255-260.
52. Whyte MP, Hughes AE: Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 2002, 17:26-29.
53. Palenzuela L, Vives-Bauza C, Fernandez-Cadenas I, et al.: Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. J Med Genet 2002, 39:E67.
54. Watts GD, Wymer J, Kovach MJ, et al.: Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004, 36:377-381.
55. Lucas GJ, Mehta SG, Hocking LJ, et al.: Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone. Bone 2006, 38:280-285.
56. Guinto JB, Ritson GP, Taylor JP, Forman MS: Valosincontaining protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy. Acta Neuropathol 2007, 114:55-61.
57. Pikkarainen M, Hartikainen P, Alafuzoff I: Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J Neuropathol Exp Neurol 2008, 67: 280-298.